Home
Reels
Groepen
Pagina
Kijk verder.....
Groepen Pagina Mijn blogs Mijn aanbiedingen Mijn vacatures Mijn cursussen Evenementen Blogs Aanbiedingen Vacatures Cursussen Forums Films Spellen
Inloggen Creëer je account
Dag Modus
TUDRIQEV Approval for Advanced Melanoma: Regulatory Progress, Mechanism, and Clinical Outlook
Replimune has reached an important milestone in oncology with the FDA’s accelerated approval of tudriqev (vusolimogene oderparepvec-wtpg), previously identified as RP1, in combination with Bristol Myers Squibb’s OPDIVO (nivolumab). Granted on August 6, 2026, the approval applies to adults with unresectable, advanced cutaneous melanoma that has progressed after treatment with an...
0 Reacties ·0 Delingen ·247 Weergaven ·0 Beoordelingen
Alsjeblieft log in to like, share and comment!
Villagge https://villagge.com